We are live on ! Find out more
AAP

Arax Advisory Partners Portfolio holdings

AUM $3.54B
1-Year Est. Return 19.14%
This Fund
S&P 500
This Quarter Est. Return
+1.51%
1 Year Est. Return
+19.14%
3 Year Est. Return
+47.9%
5 Year Est. Return
+48.74%
10 Year Est. Return
AUM
$228M
AUM Growth
+$35.2M
Cap. Flow
+$33M
Cap. Flow %
14.5%
Top 10 Hldgs %
65.61%
Holding
500
New
23
Increased
308
Reduced
86
Closed
13

Sector Composition

Rank Sector Weight
1 Financials 4.66%
2 Healthcare 3.79%
3 Technology 3.18%
4 Industrials 2.34%
5 Communication Services 2.3%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
ALL icon
151
Allstate
ALL
$67.6B
$102K 0.04%
1,122
+18
+2% +$1.71K
IEX icon
152
IDEX
IEX
$17.5B
$101K 0.04%
745
+338
+83% +$47.2K
LH icon
153
Labcorp
LH
$25.2B
$101K 0.04%
655
+301
+85% +$45.4K
RSG icon
154
Republic Services
RSG
$64.3B
$101K 0.04%
1,480
MRSH
155
Marsh
MRSH
$91.3B
$100K 0.04%
1,223
+1,189
+3,497% +$97.1K
CL icon
156
Colgate-Palmolive
CL
$73.7B
$99K 0.04%
1,536
-590
-28% -$38.6K
IWF icon
157
iShares Russell 1000 Growth ETF
IWF
$128B
$98K 0.04%
2,744
ISCV icon
158
iShares Morningstar Small-Cap Value ETF
ISCV
$711M
$96K 0.04%
1,890
+1,809
+2,233% +$90K
UPS icon
159
United Parcel Service
UPS
$92.6B
$96K 0.04%
912
+28
+3% +$3.15K
BABA icon
160
Alibaba
BABA
$309B
$95K 0.04%
517
-6
-1% -$1.14K
CVS icon
161
CVS Health
CVS
$133B
$95K 0.04%
1,488
+114
+8% +$7.51K
NVDA icon
162
NVIDIA
NVDA
$5.15T
$94K 0.04%
15,960
+360
+2% +$2.19K
SPGI icon
163
S&P Global
SPGI
$122B
$94K 0.04%
464
+119
+34% +$23.5K
NVS icon
164
Novartis
NVS
$291B
$93K 0.04%
1,378
-26
-2% -$1.79K
COR icon
165
Cencora
COR
$59.3B
$92K 0.04%
1,082
+3
+0.3% +$264
SUN icon
166
Sunoco
SUN
$14.1B
$92K 0.04%
3,721
+776
+26% +$20.6K
SYY icon
167
Sysco
SYY
$39.7B
$92K 0.04%
1,361
+383
+39% +$24.5K
CLB icon
168
Core Laboratories
CLB
$514M
$91K 0.04%
727
+368
+103% +$44.8K
DVA icon
169
DaVita
DVA
$14.9B
$91K 0.04%
1,311
+232
+22% +$15.5K
ROP icon
170
Roper Technologies
ROP
$38.7B
$91K 0.04%
330
+185
+128% +$51K
CMCSA icon
171
Comcast
CMCSA
$88B
$90K 0.04%
2,756
+655
+31% +$21.3K
IYM icon
172
iShares US Basic Materials ETF
IYM
$1.21B
$90K 0.04%
909
+32
+4% +$3.2K
BMY icon
173
Bristol-Myers Squibb
BMY
$134B
$89K 0.04%
1,620
-131
-7% -$7.08K
GM icon
174
General Motors
GM
$77.4B
$89K 0.04%
2,262
+47
+2% +$1.85K
NTT
175
DELISTED
Nippon Telegraph & Telephone
NTT
$89K 0.04%
1,974
-104
-5% -$4.69K

Similar funds

Arax Advisory Partners's Q2 2018 Portfolio in Review

As of Q2 2018, Arax Advisory Partners held 500 positions worth $228M, up 18% from $193M the previous quarter. Its ten largest holdings account for 66% of the portfolio.

Arax Advisory Partners deployed $33M of net new capital in Q2 2018, opening 23 new positions and adding to 308 existing holdings. Its largest new stake was Accenture: 3,894 shares worth $637K.

By sector, the portfolio is most concentrated in Financials at 4.7% of assets, down from 4.7% a quarter earlier, followed by Healthcare and Technology.

On the sell side, the largest reduction was Invesco Preferred ETF, an estimated $461K trimmed.

  • Arax Advisory Partners's largest Q2 2018 buy was Accenture: 3,894 shares worth $637K.
  • Arax Advisory Partners added most to Vanguard Morningstar Mid-Cap ETF in Q2 2018, an estimated $3.79M increase.
  • Arax Advisory Partners's biggest Q2 2018 reduction was Invesco Preferred ETF, cutting an estimated $461K.
  • Arax Advisory Partners fully exited Equinor in Q2 2018, selling an estimated $92K.
  • Arax Advisory Partners's ten largest holdings make up 66% of its $228M portfolio in Q2 2018.
  • Arax Advisory Partners opened 23 new positions and closed 13 in Q2 2018.
  • Arax Advisory Partners's portfolio value rose 18% quarter-over-quarter to $228M.

Based on Arax Advisory Partners's 13F filing for Q2 2018, filed 21 Aug 2018.